UA72923C2 - Заміщені похідні пурину як інгібітори клітинної адгезії - Google Patents
Заміщені похідні пурину як інгібітори клітинної адгезіїInfo
- Publication number
- UA72923C2 UA72923C2 UA2002020851A UA200220851A UA72923C2 UA 72923 C2 UA72923 C2 UA 72923C2 UA 2002020851 A UA2002020851 A UA 2002020851A UA 200220851 A UA200220851 A UA 200220851A UA 72923 C2 UA72923 C2 UA 72923C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compounds
- cell
- formula
- substituted derivatives
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Даний винахід відноситься до сполук формули І, в якій В, D, E, G, Χ, Υ, Z, R1, R2 та s мають значення, вказані у формулі винаходу, їх фізіологічно переносимi солі та їх проліки. Сполуки формули І є цінними фармакологічно активними сполуками. Вони є антагоністами рецептора вітронектину та інгібіторами клітинної адгезії і придатні для терапії та профілактики захворювань, які засновані на взаємодії між рецепторами вітронектину та їх лігандами у процесах взаємодії клітина-клітина або клітина-матриця, або яким можна запобігти, послабити або лікувати впливом на таку взаємодію. Наприклад, їх можна застосовувати для інгібування резорбції кісток остеокластами, і, таким чином, для лікування та запобігання остеопорозу, або для інгібування небажаного розвитку кровоносних судин або проліферації клітин васкулярної гладкої мускулатури. Винахід, крім того, відноситься до способів одержання сполук формули І, їх використання, особливо, як активних інгредієнтів у фармацевтичних препаратах, і фармацевтичних композицій, які містять їх.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99112637A EP1065208A1 (en) | 1999-07-02 | 1999-07-02 | Substituted purine derivatives as inhibitors of cell adhesion |
PCT/EP2000/005921 WO2001002399A1 (en) | 1999-07-02 | 2000-06-26 | Substituted purine derivatives as inhibitors of cell adhesion |
Publications (1)
Publication Number | Publication Date |
---|---|
UA72923C2 true UA72923C2 (uk) | 2005-05-16 |
Family
ID=8238483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA2002020851A UA72923C2 (uk) | 1999-07-02 | 2000-06-26 | Заміщені похідні пурину як інгібітори клітинної адгезії |
Country Status (30)
Country | Link |
---|---|
US (1) | US6747016B1 (uk) |
EP (2) | EP1065208A1 (uk) |
JP (1) | JP2003503497A (uk) |
KR (1) | KR20020015997A (uk) |
CN (1) | CN1171888C (uk) |
AR (1) | AR034242A1 (uk) |
AT (1) | ATE262528T1 (uk) |
AU (1) | AU774382B2 (uk) |
BG (1) | BG106229A (uk) |
BR (1) | BR0012050A (uk) |
CA (1) | CA2376673A1 (uk) |
CZ (1) | CZ20014553A3 (uk) |
DE (1) | DE60009296T2 (uk) |
EA (1) | EA005372B1 (uk) |
EE (1) | EE200100713A (uk) |
ES (1) | ES2219353T3 (uk) |
HU (1) | HUP0300183A3 (uk) |
IL (1) | IL147245A0 (uk) |
MX (1) | MXPA01013241A (uk) |
MY (1) | MY122631A (uk) |
NO (1) | NO20016403L (uk) |
NZ (1) | NZ516095A (uk) |
PL (1) | PL352281A1 (uk) |
SK (1) | SK18792001A3 (uk) |
TR (1) | TR200103858T2 (uk) |
TW (1) | TWI229080B (uk) |
UA (1) | UA72923C2 (uk) |
WO (1) | WO2001002399A1 (uk) |
YU (1) | YU89701A (uk) |
ZA (1) | ZA200200017B (uk) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10042655A1 (de) | 2000-08-31 | 2002-03-14 | Aventis Pharma Gmbh | Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion |
FR2847254B1 (fr) * | 2002-11-19 | 2005-01-28 | Aventis Pharma Sa | Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant |
FR2870541B1 (fr) * | 2004-05-18 | 2006-07-14 | Proskelia Sas | Derives de pyrimidines antigonistes du recepteur de la vitronectine |
PT1984344E (pt) * | 2005-12-29 | 2012-12-21 | Lexicon Pharmaceuticals Inc | Derivados de aminoácidos multicíclicos e métodos para a sua utilização |
CL2007002994A1 (es) * | 2006-10-19 | 2008-02-08 | Wyeth Corp | Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros. |
CN107450106A (zh) * | 2017-09-28 | 2017-12-08 | 北京小米移动软件有限公司 | 饮水安全提示方法、装置及智能水杯 |
EP4146639A1 (en) | 2020-05-06 | 2023-03-15 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
WO2023086319A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | 6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2190870A1 (en) * | 1994-05-27 | 1995-12-07 | George D. Hartman | Compounds for inhibiting osteoclast-mediated bone resorption |
JP2002511052A (ja) * | 1996-08-29 | 2002-04-09 | メルク エンド カンパニー インコーポレーテッド | インテグリンアンタゴニスト |
EP0946164A4 (en) * | 1996-10-30 | 2000-08-23 | Merck & Co Inc | INTEGRIN ANTAGONISTS |
DE19653646A1 (de) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung |
WO1998031359A1 (en) * | 1997-01-17 | 1998-07-23 | Merck & Co., Inc. | Integrin antagonists |
ID26219A (id) * | 1998-01-23 | 2000-12-07 | Aventis Pharma Gmbh | Turunan-turunan sulfonamida baru sebagai penghambat-penghambat resorpsi tulang dan adhesi tulang |
AU2610099A (en) | 1998-01-28 | 1999-08-16 | Danmist Aps | Method of piezoelectrically atomising and pumping fluids and piezoelectric fluidatomising and pumping device |
-
1999
- 1999-07-02 EP EP99112637A patent/EP1065208A1/en not_active Withdrawn
-
2000
- 2000-06-26 EP EP00940406A patent/EP1196416B1/en not_active Expired - Lifetime
- 2000-06-26 JP JP2001507836A patent/JP2003503497A/ja not_active Withdrawn
- 2000-06-26 HU HU0300183A patent/HUP0300183A3/hu unknown
- 2000-06-26 CZ CZ20014553A patent/CZ20014553A3/cs unknown
- 2000-06-26 US US10/030,290 patent/US6747016B1/en not_active Expired - Fee Related
- 2000-06-26 PL PL00352281A patent/PL352281A1/xx not_active Application Discontinuation
- 2000-06-26 EA EA200200121A patent/EA005372B1/ru not_active IP Right Cessation
- 2000-06-26 CN CNB008121001A patent/CN1171888C/zh not_active Expired - Fee Related
- 2000-06-26 CA CA002376673A patent/CA2376673A1/en not_active Abandoned
- 2000-06-26 WO PCT/EP2000/005921 patent/WO2001002399A1/en not_active Application Discontinuation
- 2000-06-26 AU AU55349/00A patent/AU774382B2/en not_active Ceased
- 2000-06-26 EE EEP200100713A patent/EE200100713A/xx unknown
- 2000-06-26 NZ NZ516095A patent/NZ516095A/en unknown
- 2000-06-26 SK SK1879-2001A patent/SK18792001A3/sk unknown
- 2000-06-26 TR TR2001/03858T patent/TR200103858T2/xx unknown
- 2000-06-26 ES ES00940406T patent/ES2219353T3/es not_active Expired - Lifetime
- 2000-06-26 KR KR1020017016962A patent/KR20020015997A/ko not_active Application Discontinuation
- 2000-06-26 DE DE60009296T patent/DE60009296T2/de not_active Expired - Fee Related
- 2000-06-26 MX MXPA01013241A patent/MXPA01013241A/es active IP Right Grant
- 2000-06-26 AT AT00940406T patent/ATE262528T1/de not_active IP Right Cessation
- 2000-06-26 UA UA2002020851A patent/UA72923C2/uk unknown
- 2000-06-26 IL IL14724500A patent/IL147245A0/xx unknown
- 2000-06-26 BR BR0012050-2A patent/BR0012050A/pt not_active IP Right Cessation
- 2000-06-29 MY MYPI20002961A patent/MY122631A/en unknown
- 2000-06-29 AR ARP000103314A patent/AR034242A1/es not_active Application Discontinuation
- 2000-09-01 TW TW089117924A patent/TWI229080B/zh not_active IP Right Cessation
-
2001
- 2001-12-17 BG BG106229A patent/BG106229A/bg unknown
- 2001-12-19 YU YU89701A patent/YU89701A/sh unknown
- 2001-12-28 NO NO20016403A patent/NO20016403L/no not_active Application Discontinuation
-
2002
- 2002-01-02 ZA ZA200200017A patent/ZA200200017B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY122269A (en) | Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronection receptor antagonists | |
YU47200A (sh) | Novi derivati sulfonamida kao inhibitori koštane resorpcije i kao inhibitori ćelijske adhezije | |
IL150085A0 (en) | New-p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases | |
CA2225366A1 (en) | Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them | |
MY122392A (en) | Adamantane derivatives of use of p2x7 receptor antagonists, a process for their preparation, pharmaceutical compositions containing them and a process for preparing the pharmaceutical compositions | |
CA2371789A1 (en) | Novel guanidine derivatives as inhibitors of cell adhesion | |
CL2003002042A1 (es) | Compuestos derivados de 3,9-diazabiciclo[3.3.1]noneno; composicion farmaceutica; y uso del compuesto como inhibidor de renina (ras), para tratar hipertension, insuficiencia cardiaca congestiva, hipertension pulmonar, insuficiencia renal, ateroscleros | |
MY133246A (en) | Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them | |
IL168836A (en) | Pyrimidine-sulfamides and their use as endothelin receptor antagonist | |
MXPA05010824A (es) | Compuestos biciclicos como antagonistas del receptor nr2b. | |
IL174678A0 (en) | Arylindenophyridines and arylindenophyrimidines and their use as adenosine a2a receptor antagonist | |
UA72923C2 (uk) | Заміщені похідні пурину як інгібітори клітинної адгезії | |
AU2674201A (en) | Thienylalanine derivatives as inhibitors of cell adhesion | |
DE60138893D1 (uk) | ||
DE60209014D1 (de) | Tricylische CRF Rezeptorantagonisten | |
NO20033981L (no) | Imidazolidinderivater, deres fremstilling og deres anvendelse som antiinflammatorisk middel | |
MXPA02006250A (es) | Derivados de butino diol. | |
NZ504298A (en) | 2,3-methano-amino acid compounds for treating serine protease disorders | |
NO20020886L (no) | Nye integrin- <alfa>v<beta>3-inhibitorer |